{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:16:35Z","timestamp":1787991395700,"version":"build-2784847793"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100304","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:48:44Z","timestamp":1784332124000},"page":"100304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-970X","authenticated-orcid":false,"given":"Lauren","family":"Oshman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Runyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Vicenzi Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0027-2511","authenticated-orcid":false,"given":"Patricia","family":"Arizaca-Dileo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9632-6704","authenticated-orcid":false,"given":"Ananda","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7616-6301","authenticated-orcid":false,"given":"Amal","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-4116","authenticated-orcid":false,"given":"Jonathan","family":"Gabison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-9135","authenticated-orcid":false,"given":"Amy","family":"Rothberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-2588","authenticated-orcid":false,"given":"Andrew","family":"Kraftson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2260-0299","authenticated-orcid":false,"given":"Dina","family":"Griauzde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-6742","authenticated-orcid":false,"given":"A.","family":"Mark Fendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100304_bib1","series-title":"Obesity and severe obesity prevalence in adults: united States, August 2021\u2013August 2023","author":"Emmerich","year":"2024"},{"issue":"14","key":"10.1016\/j.obpill.2026.100304_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.obpill.2026.100304_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.obpill.2026.100304_bib4","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1111\/dom.15869","article-title":"Long\u2010term safety and efficacy of glucagon\u2010like peptide\u20101 receptor agonists in individuals with obesity and without type 2 diabetes: a global retrospective cohort study","volume":"26","author":"Huang","year":"2024","journal-title":"Diabetes Obes Metabol"},{"issue":"Supplement_1","key":"10.1016\/j.obpill.2026.100304_bib5","first-page":"S183","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes\u20142026","volume":"49","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.obpill.2026.100304_bib6","author":"Klein"},{"key":"10.1016\/j.obpill.2026.100304_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2026.2615","article-title":"Medicare spending implications for semaglutide under voluntary price agreements","author":"Dusetzina","year":"2026","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.obpill.2026.100304_bib10","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.2025.4735","article-title":"Uptake of and disparities in semaglutide and tirzepatide prescribing for obesity in the US","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.obpill.2026.100304_bib11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12916-025-04200-0","article-title":"Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications","volume":"23","author":"Wu","year":"2025","journal-title":"BMC Med"},{"issue":"7","key":"10.1016\/j.obpill.2026.100304_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.37765\/ajmc.2025.89685","article-title":"Understanding insurance coverage policies for incretin mimetics for weight management","volume":"31","author":"Griauzde","year":"2025","journal-title":"Am J Manag Care"},{"issue":"Spec No. 10","key":"10.1016\/j.obpill.2026.100304_bib13","doi-asserted-by":"crossref","first-page":"SP781","DOI":"10.37765\/ajmc.2024.89614","article-title":"Rising costs lead insurers to drop weight loss drug coverage, further increasing patient burden","volume":"30","author":"Klein","year":"2024","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.obpill.2026.100304_bib14","series-title":"Why we are changing coverage of GLP-1 drugs for weight loss","year":"2024"},{"key":"10.1016\/j.obpill.2026.100304_bib15","series-title":"Medicaid coverage of and spending on GLP-1s","year":"2026"},{"key":"10.1016\/j.obpill.2026.100304_bib16","series-title":"Michigan cuts off weight-loss drugs for most Medicaid patients, saving $240M","author":"Newman","year":"2025"},{"issue":"1","key":"10.1016\/j.obpill.2026.100304_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57232","article-title":"Longitudinal analysis of obesity drug use and public awareness","volume":"8","author":"Berning","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2026.100304_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"Br Med J"},{"key":"10.1016\/j.obpill.2026.100304_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1366940","article-title":"The maintenance of long-term weight loss after semaglutide withdrawal in obese women with PCOS treated with metformin: a 2-year observational study","volume":"15","author":"Jensterle","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.obpill.2026.100304_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","volume":"69","author":"Jensen","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.obpill.2026.100304_bib21","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.1111\/dom.70096","article-title":"Treat to target in weight management with semaglutide: Real-world evidence from an eHealth clinic","volume":"27","author":"Seier","year":"2025","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.obpill.2026.100304_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/oby.70137","article-title":"Reduced-Frequency GLP1 therapy maintains weight, body composition, and metabolic syndrome improvements: a case series","author":"Wong","year":"2026","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.obpill.2026.100304_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0284474","article-title":"Primary care providers' perceived barriers to obesity treatment and opportunities for improvement: a mixed methods study","volume":"18","author":"Oshman","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.obpill.2026.100304_bib24","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s11606-021-06737-1","article-title":"A consensus-based checklist for reporting of survey studies (CROSS)","volume":"36","author":"Sharma","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.obpill.2026.100304_bib25","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/S1463423621000906","article-title":"Developing weight navigation program to support personalized and effective obesity management in primary care settings: protocol for a quality improvement program with an embedded single-arm pilot study","volume":"23","author":"Griauzde","year":"2022","journal-title":"Prim Health Care Res Dev"},{"issue":"7","key":"10.1016\/j.obpill.2026.100304_bib26","first-page":"E1","article-title":"The effect of insurance-driven medication changes on patient care","volume":"61","author":"Rood","year":"2012","journal-title":"J Fam Pract"},{"key":"10.1016\/j.obpill.2026.100304_bib27","series-title":"IBM SPSS statistics for windows (Version 30)","year":"2024"},{"issue":"9","key":"10.1016\/j.obpill.2026.100304_bib28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"issue":"4","key":"10.1016\/j.obpill.2026.100304_bib30","doi-asserted-by":"crossref","DOI":"10.1370\/afm.240633","article-title":"Coverage checker: a web-based tool to navigate diabetes coverage and prior authorization","volume":"23","author":"Kim","year":"2025","journal-title":"Ann Fam Med"},{"issue":"4","key":"10.1016\/j.obpill.2026.100304_bib31","doi-asserted-by":"crossref","first-page":"E327","DOI":"10.1001\/amajethics.2024.327","article-title":"How should we draw on pharmacists' expertise to manage drug shortages in hospitals?","volume":"26","author":"Ganio","year":"2024","journal-title":"AMA J Ethic"},{"issue":"Supplement_1","key":"10.1016\/j.obpill.2026.100304_bib33","first-page":"S167","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in Diabetes\u20132025","volume":"48","year":"2024","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.obpill.2026.100304_bib34","first-page":"1351","article-title":"American association of clinical endocrinology consensus statement: algorithm for the evaluation and treatment of adults with Obesity\/adiposity-based chronic disease - 2025 update","volume":"31","author":"Nadolsky","year":"2025","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol"},{"key":"10.1016\/j.obpill.2026.100304_bib35","doi-asserted-by":"crossref","unstructured":"Shah E, AlShiab R, Abdo A, Ozbek L, Covic A, Kanbay M. Clinical management of weight regain and cardiometabolic consequences after discontinuation of GLP\u20101 receptor agonists. doi:10.1111\/dom.70713.","DOI":"10.1111\/dom.70713"},{"issue":"11","key":"10.1016\/j.obpill.2026.100304_bib36","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.5665\/sleep.2204","article-title":"A randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine\/topiramate for the treatment of obstructive sleep apnea in obese adults","volume":"35","author":"Winslow","year":"2012","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.obpill.2026.100304_bib37","first-page":"214","article-title":"Pharmacoequity measurement framework: a tool to reduce health disparities","volume":"31","author":"Patel","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.obpill.2026.100304_bib38","article-title":"Utilization management and physician burnout | AJMC","author":"Struthers","year":"2026","journal-title":"Am J Manag Care"},{"issue":"3","key":"10.1016\/j.obpill.2026.100304_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamainternmed.2019.6326","article-title":"Professional dissonance and burnout in primary care: a qualitative study","volume":"180","author":"Agarwal","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"12","key":"10.1016\/j.obpill.2026.100304_bib40","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.47894","article-title":"Well-being parameters and intention to leave Current institution among academic physicians","volume":"6","author":"Ligibel","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.obpill.2026.100304_bib41","series-title":"Fact sheet: president donald J. Trump announces major developments in bringing most-favored-nation pricing to American patients","author":"House","year":"2025"},{"issue":"5","key":"10.1016\/j.obpill.2026.100304_bib42","first-page":"569","article-title":"Medications for obesity management: effectiveness and value: a summary from the institute for clinical and economic Review's new England comparative effectiveness public advisory council","volume":"29","author":"Atlas","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"11","key":"10.1016\/j.obpill.2026.100304_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMp2300516","article-title":"Medicare part D coverage of antiobesity medications \u2014 challenges and uncertainty ahead","volume":"388","author":"Baig","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.obpill.2026.100304_bib44","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2021.17764","article-title":"A policy prescription for reducing health disparities\u2014achieving pharmacoequity","volume":"326","author":"Essien","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.obpill.2026.100304_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.12192","article-title":"A primary care-based weight navigation program","volume":"7","author":"Griauzde","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.obpill.2026.100304_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.obpill.2026.100304_bib47","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/oby.70013","article-title":"An update on the American board of obesity medicine (ABOM): 2017-2024","volume":"33","author":"Johnson-Rabbett","year":"2025","journal-title":"Obes Silver Spring Md"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:31:32Z","timestamp":1787988692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"alternative-id":["S2667368126000604"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100304","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100304"}}